Showing results (361-370 of 3,148) with videos related to

Sort By:
Pageof 315
Neuro-Oncology|August 6, 2013
Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1αJing-Huei Lai, Hsun-Jin Jan, Li-Wen Liu, et al.
Neuro-Oncology|September 19, 2013
Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus regionMaximilian I Ruge, Philipp Kickingereder, Stefan Grau, et al.
Neuro-Oncology|September 20, 2013
New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trialsThierry Gorlia, Wenting Wu, Meihua Wang, et al.
Neuro-Oncology|August 20, 2013
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trialPaul D Brown, Stephanie Pugh, Nadia N Laack, et al.
Neuro-Oncology|June 22, 2013
Implications of Dll4-Notch signaling activation in primary glioblastoma multiformeNicolai El Hindy, Kathy Keyvani, Axel Pagenstecher, et al.
Neuro-Oncology|March 6, 2013
A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhoodKenneth J Cohen, Iris C Gibbs, Paul G Fisher, et al.
Neuro-Oncology|March 6, 2013
Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in SpainFrancesc Graus, Jordi Bruna, Javier Pardo, et al.
Neuro-Oncology|March 6, 2013
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized diseaseGabriele Calaminus, Rolf Kortmann, Jennifer Worch, et al.
Neuro-Oncology|July 2, 2013
Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesisMark Vitucci, Natalie O Karpinich, Ryan E Bash, et al.
Neuro-Oncology|July 2, 2013
MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cellsSandhya B Rani, Sachin Shivaji Rathod, Shanmuganandam Karthik, et al.
Pageof 315